Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31065 ↗At a glance
Übersichtsarbeit in Catheterization and Cardiovascular Interventions, 2024. Written by Dan Haberman and 4 co-authors. Institution: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Major MEDLINE topics: United States Food and Drug Administration, Sympathectomy, Hypertension, Renal Artery. Cited 2 times so far (Crossref); 18 references.
Abstract (original language)
Hypertension continues to be a prominent, avoidable factor contributing to major vascular issues on a global scale. Even with lifestyle adjustments and more aggressive medical treatments, maintaining optimal blood pressure levels remains challenging. This challenge has driven the emergence of device‐oriented approaches to address hypertension. To assess the safety and efficacy of the Recor Paradise Ultrasound Renal Denervation System, the Circulatory System Devices Panel was convened by the US Food and Drug Administration (FDA). This manuscript provides a condensed overview of the information put forth by the sponsor and the FDA, along with an account of the considerations and conversations that took place during the meeting.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
ORCID profiles: Ron Waksman
Cite
APA
Haberman, D., Chitturi, K. R., Lupu, L., Wermers, J. P., & Waksman, R. (2024). Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31065
Vancouver
Haberman D, Chitturi KR, Lupu L, Wermers JP, Waksman R. Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31065
BibTeX
@article{Haberman2024,
author = {Haberman, Dan and Chitturi, Kalyan R and Lupu, Lior and Wermers, Jason P and Waksman, Ron},
title = {Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31065}
}
EUVIMED